Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Baillie Gifford & Co.

Baillie Gifford & Co. lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,783,082 shares of the medical equipment provider’s stock after selling 65,465 shares during the quarter. Intuitive Surgical comprises 1.5% of Baillie Gifford & Co.’s portfolio, making the stock its 19th largest position. Baillie Gifford & Co.’s holdings in Intuitive Surgical were worth $1,974,617,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $82,517,000. Sycomore Asset Management grew its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC grew its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its stake in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 in the last three months. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. CICC Research assumed coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Royal Bank of Canada increased their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Price Performance

ISRG opened at $595.55 on Monday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $212.12 billion, a P/E ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39. The stock’s 50 day moving average price is $559.48 and its 200 day moving average price is $519.66.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.